ERβ: Recent understanding of estrogen signaling

Trends in Endocrinology and Metabolism

Volumn 21, Issue 9, 2010, Pages 545-552

  Sugiyama, Nobuhiro ^a   Barros, Rodrigo P A ^a   Warner, Margaret ^a,b   Gustafsson, Jan Åke ^a,b  

^a University of Houston   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

BRAIN; HUMAN; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; ANIMAL; BIOLOGICAL MODEL; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATE; SIGNAL TRANSDUCTION;

EID: 77956185965     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2010.05.001     Document Type: Review

References (98)

1. Editorial (2010) A decade for psychiatric disorders. Nature 463, 9.
2. Mitra S.W., et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144:2055-2067.
3. Halbreich U., et al. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry 1995, 37:434-441.
4. Osterlund M.K. Underlying mechanisms mediating the antidepressant effects of estrogens. Biochim. Biophys. Acta 2009, 10.1016/j.bbagen.2009.11.001.
5. N-Wihlbäck A.-C., et al. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology 2006, 186:388-401.
6. Schneider L.S., et al. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am. J. Geriatr. Psychiatry 2001, 9:393-399.
7. Grigoriadis S., et al. Antidepressant augmentation with raloxifene. J. Clin. Psychopharmacol. 2005, 25:96-98.
8. Sugiyama N., et al. Remarkable antidepressant augmentation effect of raloxifene, a selective estrogen receptor modulator, in a partial responder to fluvoxamine: a case report. J. Clin. Psychiatry 2007, 68:636-637.
9. Yokoyama S., et al. Five female cases of prolonged depression in chronic anorexia nervosa treated with selective estrogen receptor modulator raloxifene-augmented therapy. J. Clin. Psychopharmacol. 2008, 28:721-722.
10. Lu N.Z., et al. Ovarian steroid action on tryptophan hydroxylase protein and serotonin compared to localization of ovarian steroid receptors in midbrain of guinea pigs. Endocrine 1999, 11:257-267.
11. Gundlah C., et al. Distribution of estrogen receptor beta (ERbeta) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res. Mol. Brain Res. 2000, 76:191-204.
12. Gundlah C., et al. Estrogen receptor beta (ERbeta) mRNA and protein in serotonin neurons of macaques. Brain Res. Mol. Brain Res. 2001, 91:14-22.
13. Nomura M., et al. Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 2005, 130:445-456.
14. Vanderhorst V.G., et al. Estrogen receptor-alpha and -beta immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems. J. Comp. Neurol. 2005, 488:152-179.
15. Warembourg M., Leroy D. Comparative distribution of estrogen receptor alpha and beta immunoreactivities in the forebrain and the midbrain of the female guinea pig. Brain Res. 2004, 1002:55-66.
16. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
17. Gundlah C., et al. Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe. Biol. Psychiatry 2005, 57:938-942.
18. Imwalle D.B., et al. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol. Behav. 2005, 84:157-163.
19. Toufexis D.J., et al. Estrogen disrupts the inhibition of fear in female rats, possibly through the antagonistic effects of estrogen receptor alpha (ERalpha) and ERbeta. J. Neurosci. 2007, 27:9729-9735.
20. Morgan M.A., Pfaff D.W. Effects of estrogen on activity and fear-related behaviors in mice. Horm. Behav. 2001, 40:472-482.
21. Lund T.D., et al. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
22. Krezel W., et al. Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12278-12282.
23. Walf A.A., Frye C.A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 2005, 30:1598-1609.
24. Walf A.A., et al. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav. Neurosci. 2008, 122:974-981.
25. Frye C.A., et al. Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm. Behav. 2008, 54:726-734.
26. Osborne D.M., et al. Chronic administration of androgens with actions at estrogen receptor beta have anti-anxiety and cognitive-enhancing effects in male rats. Age (Dordr) 2009, 31:191-198.
27. Walf A.A., et al. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol. Biochem. Behav. 2004, 78:523-529.
28. Rocha B.A., et al. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology 2005, 179:637-643.
29. Walf A.A., Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol. Biochem. Behav. 2007, 86:407-414.
30. Walf A.A., et al. Antisense oligodeoxynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology 2008, 33:431-440.
31. Hughes Z.A., et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 2008, 54:1136-1142.
32. Ogawa S., et al. Behavioral effects of estrogen receptor gene disruption in male mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1476-1481.
33. Ogawa S., et al. Modifications of testosterone-dependent behaviors by estrogen receptor-alpha gene disruption in male mice. Endocrinology 1998, 139:5058-5069.
34. Ogawa S., et al. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12887-12892.
35. Nomura M., et al. Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice. Horm. Behav. 2002, 41:288-296.
36. Walf A.A., et al. Estradiol or diarylpropionitrile administration to wild type, but not estrogen receptor beta knockout, mice enhances performance in the object recognition and object placement tasks. Neurobiol. Learn. Mem. 2008, 89:513-521.
37. Liu F., et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat. Neurosci. 2008, 11:334-343.
38. Rissman E.F., et al. Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3996-4001.
39. Patisaul H.B., Bateman H.L. Neonatal exposure to endocrine active compounds or an ERbeta agonist increases adult anxiety and aggression in gonadally intact male rats. Horm. Behav. 2008, 53:580-588.
40. Fan X., et al. Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19338-19343.
41. Sugiyama N., et al. Spatiotemporal dynamics of the expression of estrogen receptors in the postnatal mouse brain. Mol. Psychiatry 2009, 14:223-232. 117.
42. Wang L., et al. Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:703-708.
43. Harada N., Yamada K. Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. Endocrinology 1992, 131:2306-2312.
44. Wang L., et al. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2792-2796.
45. Luu-The V. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 2001, 76:143-151.
46. Steckelbroeck S., et al. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 2004, 279:10784-10795.
47. Liu H., et al. Cloning and characterization of human form 2 type 7 17beta-hydroxysteroid dehydrogenase, a primarily 3beta-keto reductase and estrogen activating and androgen inactivating enzyme. J. Steroid Biochem. Mol. Biol. 2005, 94:173-179.
48. Stapleton G., et al. A novel cytochrome P450 expressed primarily in brain. J. Biol. Chem. 1995, 270:29739-29745.
49. Shehu A., et al. Prolactin receptor-associated protein/17beta-hydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival. Mol. Endocrinol. 2008, 22:2268-2277.
50. Umetani M., et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 2007, 13:1185-1192.
51. Dalla C., et al. Male aromatase-knockout mice exhibit normal levels of activity, anxiety and 'depressive-like' symptomatology. Behav. Brain Res. 2005, 163:186-193.
52. Morch L.S., et al. Hormone therapy and ovarian cancer. J. Am. Med. Assoc. 2009, 302:298-305.
53. Pike C.J., et al. Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 2009, 30:239-258.
54. Pirskanen M., et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur. J. Hum. Genet. 2005, 13:1000-1006.
55. Yaffe K., et al. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol. Aging 2009, 30:607-614.
56. Dresner-Pollak R., et al. Estrogen receptor beta gene variant is associated with vascular dementia in elderly women. Genet. Test. Mol. Biomarkers 2009, 13:339-342.
57. Wang J.M., et al. Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16983-16988.
58. Liang Y.Q., et al. Estrogen receptor beta is involved in the anorectic action of estrogen. Int. J. Obes. Relat. Metab. Disord. 2002, 26:1103-1109.
59. Eastwood H., et al. Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa. Mol. Psychiatry 2002, 7:86-89.
60. Nilsson M., et al. Association of estrogen receptor beta gene polymorphisms with bulimic disease in women. Mol. Psychiatry 2004, 9:28-34.
61. Fan X., et al. Estrogen receptor beta is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13696-13701.
62. Chakrabarty A., et al. Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system. Endocrinology 2008, 149:3452-3460.
63. Spooner M.F., et al. Endogenous pain modulation during the formalin test in estrogen receptor beta knockout mice. Neuroscience 2007, 150:675-680.
64. Gardell L.R., et al. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. Eur. J. Pharmacol. 2008, 592:158-159.
65. Zhu Y., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002, 295:505-508.
66. Somponpun S., Sladek C.D. Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro. Endocrinology 2002, 143:2899-2904.
67. Hayward S.W., Cunha G.R. The prostate: development and physiology. Radiol. Clin. North Am. 2000, 38:1-14.
68. Hoke G.P., McWilliams G.W. Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations. Am. J. Med. 2008, 121:S3-10.
69. Morani A., et al. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J. Intern. Med. 2008, 264:128-142.
70. Prins G.S., Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008, 73:233-244.
71. Ellem S.J., Risbridger G.P. The dual, opposing roles of estrogen in the prostate. Ann. N. Y. Acad. Sci. 2009, 1155:174-186.
72. Antal M.C., et al. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2433-2438.
73. Krege J.H., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15677-15682.
74. Dupont S., et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000, 127:4277-4291.
75. Shughrue P.J., et al. Estrogen-binding sites and their functional capacity in estrogen receptor double knockout mouse brain. Endocrinology 2002, 143:1643-1650.
76. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5925-5930.
77. Doetschman T. Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol. Biol. 2009, 530:423-433.
78. Harris H.A. Estrogen receptor-beta: recent lessons from in vivo studies. Mol. Endocrinol. 2007, 21:1-13.
79. Leventhal L., et al. An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain. Eur. J. Pharmacol. 2006, 553:146-148.
80. Cvoro A., et al. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J. Immunol. 2008, 180:630-636.
81. Harrington W.R., et al. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol. Cell Endocrinol. 2003, 206:13-22.
82. Bruchovsky N., Wilson J.D. The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J. Biol. Chem. 1968, 243:2012-2021.
83. Levine A.C., et al. Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate. J. Clin. Endocrinol. Metab. 1996, 81:384-389.
84. George F.W., Peterson K.G. 5alpha-dihydrotestosterone formation is necessary for embryogenesis of the rat prostate. Endocrinology 1988, 122:1159-1164.
85. Mahendroo M.S., et al. Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes. Endocrinology 2001, 142:4652-4662.
86. Isaacs J.T., et al. Characterization of two new enzymatic activities of the rat ventral prostate: 5alpha-androstane-3beta,17beta-diol 6alpha-hydroxylase and 5alpha-androstane-3beta,17beta-diol 7alpha-hydroxylase. Steroids 1979, 33:675-692.
87. Olsson M., et al. Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. Prostate 2007, 67:1439-1446.
88. Weihua Z., et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6330-6335.
89. Schulze H., Claus S. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 1990, 16:331-343.
90. Alonso-Magdalena P., et al. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2859-2863.
91. Medici D., et al. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell 2008, 19:4875-4887.
92. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
93. Ogawa S., et al. Molecular cloning and characterization of human estrogen receptor beta cx: a potential inhibitor of estrogen action in human. Nucl. Acids Res. 1998, 26:3505-3512.
94. Travis R.C., et al. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br. J. Cancer 2009, 100:1817-1823.
95. Prins G.S., et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 2001, 61:6089-6097.
96. Risbridger G., et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev. Biol. 2001, 229:432-442.
97. Ricke W.A., et al. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J. 2008, 22:1512-1520.
98. Imamov O., et al. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9375-9380.